nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—sarcoma—acquired immunodeficiency syndrome	0.43	1	CtDrD
Etoposide—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.0395	0.0936	CbGbCtD
Etoposide—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0209	0.0496	CbGbCtD
Etoposide—ABCC3—Lamivudine—acquired immunodeficiency syndrome	0.0191	0.0454	CbGbCtD
Etoposide—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.018	0.0428	CbGbCtD
Etoposide—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0158	0.0376	CbGbCtD
Etoposide—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0158	0.0376	CbGbCtD
Etoposide—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0134	0.0317	CbGbCtD
Etoposide—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0117	0.0279	CbGbCtD
Etoposide—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0117	0.0278	CbGbCtD
Etoposide—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0117	0.0278	CbGbCtD
Etoposide—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0117	0.0278	CbGbCtD
Etoposide—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0106	0.0251	CbGbCtD
Etoposide—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0106	0.0251	CbGbCtD
Etoposide—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0102	0.0241	CbGbCtD
Etoposide—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0087	0.0206	CbGbCtD
Etoposide—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00857	0.0203	CbGbCtD
Etoposide—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.00786	0.0186	CbGbCtD
Etoposide—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00775	0.0184	CbGbCtD
Etoposide—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00775	0.0184	CbGbCtD
Etoposide—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.00756	0.0179	CbGbCtD
Etoposide—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00745	0.0177	CbGbCtD
Etoposide—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00745	0.0177	CbGbCtD
Etoposide—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00678	0.0161	CbGbCtD
Etoposide—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00669	0.0159	CbGbCtD
Etoposide—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00649	0.0154	CbGbCtD
Etoposide—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.00638	0.0151	CbGbCtD
Etoposide—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.00638	0.0151	CbGbCtD
Etoposide—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00587	0.0139	CbGbCtD
Etoposide—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00587	0.0139	CbGbCtD
Etoposide—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00577	0.0137	CbGbCtD
Etoposide—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00565	0.0134	CbGbCtD
Etoposide—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00565	0.0134	CbGbCtD
Etoposide—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00558	0.0132	CbGbCtD
Etoposide—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00541	0.0128	CbGbCtD
Etoposide—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00504	0.012	CbGbCtD
Etoposide—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00483	0.0115	CbGbCtD
Etoposide—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00437	0.0104	CbGbCtD
Etoposide—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00435	0.0103	CbGbCtD
Etoposide—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00423	0.01	CbGbCtD
Etoposide—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00382	0.00906	CbGbCtD
Etoposide—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00382	0.00906	CbGbCtD
Etoposide—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00366	0.00869	CbGbCtD
Etoposide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00355	0.00843	CbGbCtD
Etoposide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00334	0.00792	CbGbCtD
Etoposide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00334	0.00792	CbGbCtD
Etoposide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00302	0.00717	CbGbCtD
Etoposide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00302	0.00717	CbGbCtD
Etoposide—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00283	0.00672	CbGbCtD
Etoposide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00261	0.00619	CbGbCtD
Etoposide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00253	0.00601	CbGbCtD
Etoposide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00229	0.00543	CbGbCtD
Etoposide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00229	0.00543	CbGbCtD
Etoposide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0022	0.00521	CbGbCtD
Etoposide—ABCC6—blood plasma—acquired immunodeficiency syndrome	0.00141	0.0378	CbGeAlD
Etoposide—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00102	0.0274	CbGeAlD
Etoposide—ABCC3—blood plasma—acquired immunodeficiency syndrome	0.000804	0.0216	CbGeAlD
Etoposide—GSTP1—blood plasma—acquired immunodeficiency syndrome	0.000801	0.0215	CbGeAlD
Etoposide—ABCC6—retina—acquired immunodeficiency syndrome	0.000771	0.0207	CbGeAlD
Etoposide—TOP2B—retina—acquired immunodeficiency syndrome	0.0007	0.0188	CbGeAlD
Etoposide—GSTT1—lymphoid tissue—acquired immunodeficiency syndrome	0.000676	0.0181	CbGeAlD
Etoposide—GSTT1—digestive system—acquired immunodeficiency syndrome	0.000667	0.0179	CbGeAlD
Etoposide—GSTT1—blood—acquired immunodeficiency syndrome	0.000636	0.0171	CbGeAlD
Etoposide—GSTT1—lung—acquired immunodeficiency syndrome	0.000557	0.015	CbGeAlD
Etoposide—GSTT1—nervous system—acquired immunodeficiency syndrome	0.000516	0.0139	CbGeAlD
Etoposide—ABCC6—blood—acquired immunodeficiency syndrome	0.000516	0.0139	CbGeAlD
Etoposide—TOP2B—lymphoid tissue—acquired immunodeficiency syndrome	0.000498	0.0134	CbGeAlD
Etoposide—TOP2B—digestive system—acquired immunodeficiency syndrome	0.000492	0.0132	CbGeAlD
Etoposide—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000482	0.0129	CbGeAlD
Etoposide—TOP2B—blood—acquired immunodeficiency syndrome	0.000468	0.0126	CbGeAlD
Etoposide—TOP2B—bone marrow—acquired immunodeficiency syndrome	0.000453	0.0122	CbGeAlD
Etoposide—ABCC6—lung—acquired immunodeficiency syndrome	0.000452	0.0121	CbGeAlD
Etoposide—TOP2B—spinal cord—acquired immunodeficiency syndrome	0.000451	0.0121	CbGeAlD
Etoposide—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000451	0.0121	CbGeAlD
Etoposide—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00044	0.0118	CbGeAlD
Etoposide—GSTP1—retina—acquired immunodeficiency syndrome	0.000438	0.0118	CbGeAlD
Etoposide—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000435	0.0117	CbGeAlD
Etoposide—TOP2B—vagina—acquired immunodeficiency syndrome	0.000434	0.0117	CbGeAlD
Etoposide—PTGS2—endothelium—acquired immunodeficiency syndrome	0.000421	0.0113	CbGeAlD
Etoposide—TOP2B—lung—acquired immunodeficiency syndrome	0.000411	0.011	CbGeAlD
Etoposide—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000406	0.0109	CbGeAlD
Etoposide—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.000392	0.0105	CbGeAlD
Etoposide—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000391	0.0105	CbGeAlD
Etoposide—GSTP1—skin of body—acquired immunodeficiency syndrome	0.000385	0.0103	CbGeAlD
Etoposide—TOP2A—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.000381	0.271	CbGdCrCtD
Etoposide—TOP2B—nervous system—acquired immunodeficiency syndrome	0.00038	0.0102	CbGeAlD
Etoposide—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.000374	0.01	CbGeAlD
Etoposide—UGT1A1—blood—acquired immunodeficiency syndrome	0.000373	0.01	CbGeAlD
Etoposide—TOP2B—central nervous system—acquired immunodeficiency syndrome	0.000366	0.00983	CbGeAlD
Etoposide—TOP2A—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.000349	0.248	CbGdCrCtD
Etoposide—TOP2A—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.000349	0.248	CbGdCrCtD
Etoposide—TOP2A—blood—acquired immunodeficiency syndrome	0.000344	0.00925	CbGeAlD
Etoposide—TOP2A—bone marrow—acquired immunodeficiency syndrome	0.000333	0.00895	CbGeAlD
Etoposide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000326	0.00877	CbGeAlD
Etoposide—TOP2A—vagina—acquired immunodeficiency syndrome	0.000319	0.00857	CbGeAlD
Etoposide—GSTP1—lymphoid tissue—acquired immunodeficiency syndrome	0.000312	0.00837	CbGeAlD
Etoposide—ABCC10—lymphoid tissue—acquired immunodeficiency syndrome	0.000312	0.00837	CbGeAlD
Etoposide—ABCC3—digestive system—acquired immunodeficiency syndrome	0.000309	0.0083	CbGeAlD
Etoposide—GSTP1—digestive system—acquired immunodeficiency syndrome	0.000308	0.00827	CbGeAlD
Etoposide—ABCC10—digestive system—acquired immunodeficiency syndrome	0.000308	0.00826	CbGeAlD
Etoposide—TOP2A—lung—acquired immunodeficiency syndrome	0.000302	0.00811	CbGeAlD
Etoposide—ABCC3—blood—acquired immunodeficiency syndrome	0.000295	0.00791	CbGeAlD
Etoposide—GSTP1—blood—acquired immunodeficiency syndrome	0.000293	0.00788	CbGeAlD
Etoposide—ABCC10—blood—acquired immunodeficiency syndrome	0.000293	0.00787	CbGeAlD
Etoposide—TOP2B—brain—acquired immunodeficiency syndrome	0.000291	0.0078	CbGeAlD
Etoposide—GSTP1—bone marrow—acquired immunodeficiency syndrome	0.000284	0.00762	CbGeAlD
Etoposide—ABCC10—bone marrow—acquired immunodeficiency syndrome	0.000284	0.00762	CbGeAlD
Etoposide—GSTP1—spinal cord—acquired immunodeficiency syndrome	0.000283	0.00759	CbGeAlD
Etoposide—ABCC10—spinal cord—acquired immunodeficiency syndrome	0.000282	0.00758	CbGeAlD
Etoposide—TOP2B—lymph node—acquired immunodeficiency syndrome	0.000281	0.00754	CbGeAlD
Etoposide—GSTP1—vagina—acquired immunodeficiency syndrome	0.000272	0.0073	CbGeAlD
Etoposide—ABCC10—vagina—acquired immunodeficiency syndrome	0.000272	0.0073	CbGeAlD
Etoposide—ABCC3—lung—acquired immunodeficiency syndrome	0.000258	0.00693	CbGeAlD
Etoposide—GSTP1—lung—acquired immunodeficiency syndrome	0.000257	0.00691	CbGeAlD
Etoposide—ABCC10—lung—acquired immunodeficiency syndrome	0.000257	0.0069	CbGeAlD
Etoposide—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000247	0.00663	CbGeAlD
Etoposide—ABCC3—nervous system—acquired immunodeficiency syndrome	0.000239	0.00642	CbGeAlD
Etoposide—GSTP1—nervous system—acquired immunodeficiency syndrome	0.000238	0.00639	CbGeAlD
Etoposide—ABCC2—blood—acquired immunodeficiency syndrome	0.000235	0.00632	CbGeAlD
Etoposide—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000231	0.0062	CbGeAlD
Etoposide—ABCC3—central nervous system—acquired immunodeficiency syndrome	0.00023	0.00618	CbGeAlD
Etoposide—GSTP1—central nervous system—acquired immunodeficiency syndrome	0.000229	0.00616	CbGeAlD
Etoposide—ABCC1—blood—acquired immunodeficiency syndrome	0.000207	0.00557	CbGeAlD
Etoposide—TOP2A—lymph node—acquired immunodeficiency syndrome	0.000206	0.00554	CbGeAlD
Etoposide—ABCC1—vagina—acquired immunodeficiency syndrome	0.000192	0.00516	CbGeAlD
Etoposide—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000188	0.00505	CbGeAlD
Etoposide—ABCC3—brain—acquired immunodeficiency syndrome	0.000183	0.00491	CbGeAlD
Etoposide—GSTP1—brain—acquired immunodeficiency syndrome	0.000182	0.00489	CbGeAlD
Etoposide—ABCC10—brain—acquired immunodeficiency syndrome	0.000182	0.00488	CbGeAlD
Etoposide—ABCC1—lung—acquired immunodeficiency syndrome	0.000182	0.00488	CbGeAlD
Etoposide—PTGS2—skin of body—acquired immunodeficiency syndrome	0.00018	0.00482	CbGeAlD
Etoposide—ABCC3—lymph node—acquired immunodeficiency syndrome	0.000177	0.00474	CbGeAlD
Etoposide—CYP2C8—blood—acquired immunodeficiency syndrome	0.000177	0.00474	CbGeAlD
Etoposide—GSTP1—lymph node—acquired immunodeficiency syndrome	0.000176	0.00472	CbGeAlD
Etoposide—ABCC10—lymph node—acquired immunodeficiency syndrome	0.000176	0.00472	CbGeAlD
Etoposide—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000173	0.00466	CbGeAlD
Etoposide—ABCG2—blood—acquired immunodeficiency syndrome	0.000172	0.00461	CbGeAlD
Etoposide—TOP2A—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.122	CbGdCrCtD
Etoposide—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000167	0.00449	CbGeAlD
Etoposide—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000166	0.00446	CbGeAlD
Etoposide—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000165	0.00444	CbGeAlD
Etoposide—CYP1A2—blood—acquired immunodeficiency syndrome	0.000165	0.00444	CbGeAlD
Etoposide—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000164	0.00439	CbGeAlD
Etoposide—CYP3A5—blood—acquired immunodeficiency syndrome	0.000159	0.00428	CbGeAlD
Etoposide—ABCG2—vagina—acquired immunodeficiency syndrome	0.000159	0.00427	CbGeAlD
Etoposide—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000158	0.00424	CbGeAlD
Etoposide—TOP2A—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.112	CbGdCrCtD
Etoposide—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000156	0.00419	CbGeAlD
Etoposide—ABCG2—lung—acquired immunodeficiency syndrome	0.00015	0.00404	CbGeAlD
Etoposide—PTGS1—digestive system—acquired immunodeficiency syndrome	0.00015	0.00404	CbGeAlD
Etoposide—CYP2E1—blood—acquired immunodeficiency syndrome	0.000149	0.00399	CbGeAlD
Etoposide—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000148	0.00397	CbGeAlD
Etoposide—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000145	0.0039	CbGeAlD
Etoposide—CYP1A2—lung—acquired immunodeficiency syndrome	0.000145	0.00389	CbGeAlD
Etoposide—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000144	0.00386	CbGeAlD
Etoposide—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000143	0.00384	CbGeAlD
Etoposide—PTGS1—blood—acquired immunodeficiency syndrome	0.000143	0.00384	CbGeAlD
Etoposide—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000141	0.00379	CbGeAlD
Etoposide—CYP3A5—lung—acquired immunodeficiency syndrome	0.00014	0.00375	CbGeAlD
Etoposide—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000138	0.0037	CbGeAlD
Etoposide—PTGS2—blood—acquired immunodeficiency syndrome	0.000137	0.00367	CbGeAlD
Etoposide—PTGS1—vagina—acquired immunodeficiency syndrome	0.000133	0.00356	CbGeAlD
Etoposide—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000132	0.00356	CbGeAlD
Etoposide—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000132	0.00354	CbGeAlD
Etoposide—CYP2E1—lung—acquired immunodeficiency syndrome	0.00013	0.0035	CbGeAlD
Etoposide—ABCC1—brain—acquired immunodeficiency syndrome	0.000129	0.00345	CbGeAlD
Etoposide—PTGS2—vagina—acquired immunodeficiency syndrome	0.000127	0.00341	CbGeAlD
Etoposide—ABCB1—retina—acquired immunodeficiency syndrome	0.000127	0.0034	CbGeAlD
Etoposide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000126	0.00337	CbGeAlD
Etoposide—PTGS1—lung—acquired immunodeficiency syndrome	0.000126	0.00337	CbGeAlD
Etoposide—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000124	0.00334	CbGeAlD
Etoposide—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000121	0.00324	CbGeAlD
Etoposide—PTGS2—lung—acquired immunodeficiency syndrome	0.00012	0.00322	CbGeAlD
Etoposide—CYP3A4—blood—acquired immunodeficiency syndrome	0.00012	0.00321	CbGeAlD
Etoposide—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000116	0.00312	CbGeAlD
Etoposide—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000116	0.00312	CbGeAlD
Etoposide—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000112	0.003	CbGeAlD
Etoposide—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000111	0.00298	CbGeAlD
Etoposide—CYP2C8—brain—acquired immunodeficiency syndrome	0.00011	0.00294	CbGeAlD
Etoposide—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000107	0.00287	CbGeAlD
Etoposide—ABCG2—brain—acquired immunodeficiency syndrome	0.000107	0.00286	CbGeAlD
Etoposide—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000103	0.00276	CbGeAlD
Etoposide—CYP3A4—nervous system—acquired immunodeficiency syndrome	9.71e-05	0.00261	CbGeAlD
Etoposide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	9.35e-05	0.00251	CbGeAlD
Etoposide—CYP2E1—brain—acquired immunodeficiency syndrome	9.22e-05	0.00248	CbGeAlD
Etoposide—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	8.99e-05	0.00242	CbGeAlD
Etoposide—ABCB1—digestive system—acquired immunodeficiency syndrome	8.88e-05	0.00239	CbGeAlD
Etoposide—PTGS1—brain—acquired immunodeficiency syndrome	8.88e-05	0.00239	CbGeAlD
Etoposide—PTGS1—lymph node—acquired immunodeficiency syndrome	8.58e-05	0.0023	CbGeAlD
Etoposide—PTGS2—brain—acquired immunodeficiency syndrome	8.49e-05	0.00228	CbGeAlD
Etoposide—ABCB1—blood—acquired immunodeficiency syndrome	8.46e-05	0.00227	CbGeAlD
Etoposide—Vomiting—Didanosine—acquired immunodeficiency syndrome	8.32e-05	0.000761	CcSEcCtD
Etoposide—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	8.3e-05	0.000759	CcSEcCtD
Etoposide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	8.27e-05	0.000756	CcSEcCtD
Etoposide—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	8.27e-05	0.000756	CcSEcCtD
Etoposide—Rash—Didanosine—acquired immunodeficiency syndrome	8.25e-05	0.000754	CcSEcCtD
Etoposide—Infection—Delavirdine—acquired immunodeficiency syndrome	8.25e-05	0.000754	CcSEcCtD
Etoposide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	8.25e-05	0.000754	CcSEcCtD
Etoposide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	8.25e-05	0.000754	CcSEcCtD
Etoposide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	8.24e-05	0.000754	CcSEcCtD
Etoposide—Cough—Ritonavir—acquired immunodeficiency syndrome	8.21e-05	0.00075	CcSEcCtD
Etoposide—PTGS2—lymph node—acquired immunodeficiency syndrome	8.2e-05	0.0022	CbGeAlD
Etoposide—Headache—Didanosine—acquired immunodeficiency syndrome	8.2e-05	0.000749	CcSEcCtD
Etoposide—ABCB1—bone marrow—acquired immunodeficiency syndrome	8.19e-05	0.0022	CbGeAlD
Etoposide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	8.19e-05	0.000748	CcSEcCtD
Etoposide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	8.18e-05	0.000747	CcSEcCtD
Etoposide—Malaise—Saquinavir—acquired immunodeficiency syndrome	8.16e-05	0.000746	CcSEcCtD
Etoposide—Somnolence—Indinavir—acquired immunodeficiency syndrome	8.16e-05	0.000746	CcSEcCtD
Etoposide—ABCB1—spinal cord—acquired immunodeficiency syndrome	8.15e-05	0.00219	CbGeAlD
Etoposide—Asthenia—Stavudine—acquired immunodeficiency syndrome	8.15e-05	0.000745	CcSEcCtD
Etoposide—Convulsion—Ritonavir—acquired immunodeficiency syndrome	8.15e-05	0.000745	CcSEcCtD
Etoposide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	8.14e-05	0.000744	CcSEcCtD
Etoposide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	8.13e-05	0.000744	CcSEcCtD
Etoposide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	8.13e-05	0.000743	CcSEcCtD
Etoposide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	8.12e-05	0.000742	CcSEcCtD
Etoposide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	8.1e-05	0.000741	CcSEcCtD
Etoposide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	8.1e-05	0.000741	CcSEcCtD
Etoposide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	8.07e-05	0.000738	CcSEcCtD
Etoposide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	8.06e-05	0.000737	CcSEcCtD
Etoposide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	8.06e-05	0.000737	CcSEcCtD
Etoposide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	8.05e-05	0.000736	CcSEcCtD
Etoposide—Pruritus—Stavudine—acquired immunodeficiency syndrome	8.04e-05	0.000735	CcSEcCtD
Etoposide—Asthenia—Abacavir—acquired immunodeficiency syndrome	8.03e-05	0.000734	CcSEcCtD
Etoposide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	8.03e-05	0.000734	CcSEcCtD
Etoposide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	8.01e-05	0.000733	CcSEcCtD
Etoposide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	8.01e-05	0.000732	CcSEcCtD
Etoposide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	7.98e-05	0.00073	CcSEcCtD
Etoposide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	7.98e-05	0.00073	CcSEcCtD
Etoposide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	7.96e-05	0.000727	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	7.95e-05	0.000727	CcSEcCtD
Etoposide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	7.93e-05	0.000725	CcSEcCtD
Etoposide—Pruritus—Abacavir—acquired immunodeficiency syndrome	7.92e-05	0.000724	CcSEcCtD
Etoposide—Fatigue—Indinavir—acquired immunodeficiency syndrome	7.92e-05	0.000724	CcSEcCtD
Etoposide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	7.91e-05	0.000723	CcSEcCtD
Etoposide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	7.91e-05	0.000723	CcSEcCtD
Etoposide—Cough—Saquinavir—acquired immunodeficiency syndrome	7.9e-05	0.000722	CcSEcCtD
Etoposide—Pain—Indinavir—acquired immunodeficiency syndrome	7.85e-05	0.000718	CcSEcCtD
Etoposide—Constipation—Indinavir—acquired immunodeficiency syndrome	7.85e-05	0.000718	CcSEcCtD
Etoposide—ABCB1—vagina—acquired immunodeficiency syndrome	7.85e-05	0.00211	CbGeAlD
Etoposide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	7.84e-05	0.000717	CcSEcCtD
Etoposide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	7.84e-05	0.000717	CcSEcCtD
Etoposide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	7.82e-05	0.000715	CcSEcCtD
Etoposide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	7.81e-05	0.000714	CcSEcCtD
Etoposide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	7.81e-05	0.000714	CcSEcCtD
Etoposide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	7.8e-05	0.000713	CcSEcCtD
Etoposide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	7.79e-05	0.000712	CcSEcCtD
Etoposide—Malaise—Lamivudine—acquired immunodeficiency syndrome	7.79e-05	0.000712	CcSEcCtD
Etoposide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	7.77e-05	0.000711	CcSEcCtD
Etoposide—Nausea—Didanosine—acquired immunodeficiency syndrome	7.77e-05	0.000711	CcSEcCtD
Etoposide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	7.76e-05	0.000709	CcSEcCtD
Etoposide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	7.76e-05	0.000709	CcSEcCtD
Etoposide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	7.74e-05	0.000708	CcSEcCtD
Etoposide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	7.74e-05	0.000707	CcSEcCtD
Etoposide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	7.73e-05	0.000707	CcSEcCtD
Etoposide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	7.71e-05	0.000705	CcSEcCtD
Etoposide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.000705	CcSEcCtD
Etoposide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	7.66e-05	0.0007	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	7.65e-05	0.0007	CcSEcCtD
Etoposide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	7.62e-05	0.000696	CcSEcCtD
Etoposide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	7.59e-05	0.000694	CcSEcCtD
Etoposide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	7.57e-05	0.000692	CcSEcCtD
Etoposide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	7.54e-05	0.000689	CcSEcCtD
Etoposide—Cough—Lamivudine—acquired immunodeficiency syndrome	7.54e-05	0.000689	CcSEcCtD
Etoposide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	7.54e-05	0.000689	CcSEcCtD
Etoposide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	7.52e-05	0.000687	CcSEcCtD
Etoposide—Dizziness—Stavudine—acquired immunodeficiency syndrome	7.51e-05	0.000687	CcSEcCtD
Etoposide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	7.51e-05	0.000686	CcSEcCtD
Etoposide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	7.49e-05	0.000685	CcSEcCtD
Etoposide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	7.49e-05	0.000685	CcSEcCtD
Etoposide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	7.48e-05	0.000684	CcSEcCtD
Etoposide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.48e-05	0.000684	CcSEcCtD
Etoposide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.48e-05	0.000684	CcSEcCtD
Etoposide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	7.46e-05	0.000682	CcSEcCtD
Etoposide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	7.45e-05	0.000681	CcSEcCtD
Etoposide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	7.45e-05	0.000681	CcSEcCtD
Etoposide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	7.42e-05	0.000678	CcSEcCtD
Etoposide—ABCB1—lung—acquired immunodeficiency syndrome	7.42e-05	0.00199	CbGeAlD
Etoposide—Constipation—Efavirenz—acquired immunodeficiency syndrome	7.42e-05	0.000678	CcSEcCtD
Etoposide—Pain—Efavirenz—acquired immunodeficiency syndrome	7.42e-05	0.000678	CcSEcCtD
Etoposide—Rash—Nevirapine—acquired immunodeficiency syndrome	7.42e-05	0.000678	CcSEcCtD
Etoposide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.41e-05	0.000678	CcSEcCtD
Etoposide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	7.4e-05	0.000677	CcSEcCtD
Etoposide—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.4e-05	0.000677	CcSEcCtD
Etoposide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	7.38e-05	0.000675	CcSEcCtD
Etoposide—Headache—Nevirapine—acquired immunodeficiency syndrome	7.37e-05	0.000674	CcSEcCtD
Etoposide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	7.35e-05	0.000672	CcSEcCtD
Etoposide—Infection—Saquinavir—acquired immunodeficiency syndrome	7.34e-05	0.000671	CcSEcCtD
Etoposide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	7.32e-05	0.000669	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	7.3e-05	0.000668	CcSEcCtD
Etoposide—Urticaria—Indinavir—acquired immunodeficiency syndrome	7.3e-05	0.000667	CcSEcCtD
Etoposide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	7.27e-05	0.000664	CcSEcCtD
Etoposide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.000664	CcSEcCtD
Etoposide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.000664	CcSEcCtD
Etoposide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	7.25e-05	0.000662	CcSEcCtD
Etoposide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	7.23e-05	0.000661	CcSEcCtD
Etoposide—Vomiting—Stavudine—acquired immunodeficiency syndrome	7.22e-05	0.00066	CcSEcCtD
Etoposide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	7.22e-05	0.00066	CcSEcCtD
Etoposide—Rash—Nelfinavir—acquired immunodeficiency syndrome	7.19e-05	0.000657	CcSEcCtD
Etoposide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	7.18e-05	0.000656	CcSEcCtD
Etoposide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	7.18e-05	0.000656	CcSEcCtD
Etoposide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	7.17e-05	0.000656	CcSEcCtD
Etoposide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	7.17e-05	0.000655	CcSEcCtD
Etoposide—Rash—Stavudine—acquired immunodeficiency syndrome	7.16e-05	0.000655	CcSEcCtD
Etoposide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	7.16e-05	0.000654	CcSEcCtD
Etoposide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	7.16e-05	0.000654	CcSEcCtD
Etoposide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	7.15e-05	0.000654	CcSEcCtD
Etoposide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	7.14e-05	0.000653	CcSEcCtD
Etoposide—Headache—Nelfinavir—acquired immunodeficiency syndrome	7.14e-05	0.000653	CcSEcCtD
Etoposide—Headache—Stavudine—acquired immunodeficiency syndrome	7.12e-05	0.000651	CcSEcCtD
Etoposide—Vomiting—Abacavir—acquired immunodeficiency syndrome	7.12e-05	0.00065	CcSEcCtD
Etoposide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.00065	CcSEcCtD
Etoposide—Pain—Delavirdine—acquired immunodeficiency syndrome	7.1e-05	0.000649	CcSEcCtD
Etoposide—Constipation—Delavirdine—acquired immunodeficiency syndrome	7.1e-05	0.000649	CcSEcCtD
Etoposide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	7.1e-05	0.000649	CcSEcCtD
Etoposide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	7.08e-05	0.000648	CcSEcCtD
Etoposide—Rash—Abacavir—acquired immunodeficiency syndrome	7.06e-05	0.000645	CcSEcCtD
Etoposide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	7.05e-05	0.000644	CcSEcCtD
Etoposide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	7.05e-05	0.000644	CcSEcCtD
Etoposide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	7.04e-05	0.000644	CcSEcCtD
Etoposide—Headache—Abacavir—acquired immunodeficiency syndrome	7.01e-05	0.000641	CcSEcCtD
Etoposide—Infection—Lamivudine—acquired immunodeficiency syndrome	7e-05	0.00064	CcSEcCtD
Etoposide—Nausea—Nevirapine—acquired immunodeficiency syndrome	6.99e-05	0.000639	CcSEcCtD
Etoposide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	6.99e-05	0.000639	CcSEcCtD
Etoposide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	6.9e-05	0.000631	CcSEcCtD
Etoposide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	6.9e-05	0.000631	CcSEcCtD
Etoposide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	6.89e-05	0.00063	CcSEcCtD
Etoposide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	6.89e-05	0.00063	CcSEcCtD
Etoposide—ABCB1—nervous system—acquired immunodeficiency syndrome	6.87e-05	0.00185	CbGeAlD
Etoposide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000627	CcSEcCtD
Etoposide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000627	CcSEcCtD
Etoposide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	6.85e-05	0.000626	CcSEcCtD
Etoposide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	6.84e-05	0.000626	CcSEcCtD
Etoposide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	6.84e-05	0.000625	CcSEcCtD
Etoposide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	6.82e-05	0.000624	CcSEcCtD
Etoposide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	6.81e-05	0.000623	CcSEcCtD
Etoposide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.79e-05	0.000621	CcSEcCtD
Etoposide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.77e-05	0.000619	CcSEcCtD
Etoposide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6.77e-05	0.000618	CcSEcCtD
Etoposide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	6.76e-05	0.000618	CcSEcCtD
Etoposide—Nausea—Stavudine—acquired immunodeficiency syndrome	6.75e-05	0.000617	CcSEcCtD
Etoposide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	6.72e-05	0.000614	CcSEcCtD
Etoposide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	6.67e-05	0.00061	CcSEcCtD
Etoposide—Nausea—Abacavir—acquired immunodeficiency syndrome	6.65e-05	0.000608	CcSEcCtD
Etoposide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	6.63e-05	0.000607	CcSEcCtD
Etoposide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	6.63e-05	0.000606	CcSEcCtD
Etoposide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.62e-05	0.000605	CcSEcCtD
Etoposide—ABCB1—central nervous system—acquired immunodeficiency syndrome	6.62e-05	0.00178	CbGeAlD
Etoposide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	6.6e-05	0.000603	CcSEcCtD
Etoposide—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.59e-05	0.000602	CcSEcCtD
Etoposide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	6.59e-05	0.000602	CcSEcCtD
Etoposide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	6.59e-05	0.000602	CcSEcCtD
Etoposide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	6.57e-05	0.0006	CcSEcCtD
Etoposide—Constipation—Ritonavir—acquired immunodeficiency syndrome	6.56e-05	0.0006	CcSEcCtD
Etoposide—Pain—Ritonavir—acquired immunodeficiency syndrome	6.56e-05	0.0006	CcSEcCtD
Etoposide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	6.56e-05	0.0006	CcSEcCtD
Etoposide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	6.56e-05	0.0006	CcSEcCtD
Etoposide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.53e-05	0.000597	CcSEcCtD
Etoposide—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.5e-05	0.000594	CcSEcCtD
Etoposide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6.42e-05	0.000587	CcSEcCtD
Etoposide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	6.39e-05	0.000584	CcSEcCtD
Etoposide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.38e-05	0.000583	CcSEcCtD
Etoposide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.37e-05	0.000582	CcSEcCtD
Etoposide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	6.33e-05	0.000579	CcSEcCtD
Etoposide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	6.33e-05	0.000578	CcSEcCtD
Etoposide—Pain—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000578	CcSEcCtD
Etoposide—Constipation—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000578	CcSEcCtD
Etoposide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	6.28e-05	0.000574	CcSEcCtD
Etoposide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	6.28e-05	0.000574	CcSEcCtD
Etoposide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.28e-05	0.000574	CcSEcCtD
Etoposide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	6.28e-05	0.000574	CcSEcCtD
Etoposide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	6.27e-05	0.000573	CcSEcCtD
Etoposide—Rash—Zidovudine—acquired immunodeficiency syndrome	6.23e-05	0.000569	CcSEcCtD
Etoposide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	6.23e-05	0.000569	CcSEcCtD
Etoposide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	6.22e-05	0.000569	CcSEcCtD
Etoposide—Headache—Zidovudine—acquired immunodeficiency syndrome	6.19e-05	0.000565	CcSEcCtD
Etoposide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	6.14e-05	0.000561	CcSEcCtD
Etoposide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	6.13e-05	0.00056	CcSEcCtD
Etoposide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	6.12e-05	0.000559	CcSEcCtD
Etoposide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	6.1e-05	0.000557	CcSEcCtD
Etoposide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	6.09e-05	0.000557	CcSEcCtD
Etoposide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	6.09e-05	0.000556	CcSEcCtD
Etoposide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	6.08e-05	0.000556	CcSEcCtD
Etoposide—Dizziness—Indinavir—acquired immunodeficiency syndrome	6.07e-05	0.000555	CcSEcCtD
Etoposide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000555	CcSEcCtD
Etoposide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000555	CcSEcCtD
Etoposide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	6.04e-05	0.000552	CcSEcCtD
Etoposide—Constipation—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000551	CcSEcCtD
Etoposide—Pain—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000551	CcSEcCtD
Etoposide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.96e-05	0.000544	CcSEcCtD
Etoposide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.94e-05	0.000543	CcSEcCtD
Etoposide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.87e-05	0.000537	CcSEcCtD
Etoposide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.87e-05	0.000537	CcSEcCtD
Etoposide—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.87e-05	0.000536	CcSEcCtD
Etoposide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000534	CcSEcCtD
Etoposide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000534	CcSEcCtD
Etoposide—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.84e-05	0.000534	CcSEcCtD
Etoposide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	5.81e-05	0.000531	CcSEcCtD
Etoposide—Rash—Indinavir—acquired immunodeficiency syndrome	5.79e-05	0.000529	CcSEcCtD
Etoposide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.78e-05	0.000529	CcSEcCtD
Etoposide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.76e-05	0.000527	CcSEcCtD
Etoposide—Headache—Indinavir—acquired immunodeficiency syndrome	5.75e-05	0.000526	CcSEcCtD
Etoposide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	5.74e-05	0.000524	CcSEcCtD
Etoposide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.68e-05	0.000519	CcSEcCtD
Etoposide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.66e-05	0.000517	CcSEcCtD
Etoposide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.6e-05	0.000512	CcSEcCtD
Etoposide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.57e-05	0.000509	CcSEcCtD
Etoposide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	5.57e-05	0.000509	CcSEcCtD
Etoposide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.52e-05	0.000504	CcSEcCtD
Etoposide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.51e-05	0.000503	CcSEcCtD
Etoposide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.49e-05	0.000502	CcSEcCtD
Etoposide—Rash—Efavirenz—acquired immunodeficiency syndrome	5.47e-05	0.0005	CcSEcCtD
Etoposide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.47e-05	0.0005	CcSEcCtD
Etoposide—Nausea—Indinavir—acquired immunodeficiency syndrome	5.45e-05	0.000499	CcSEcCtD
Etoposide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	5.44e-05	0.000498	CcSEcCtD
Etoposide—Headache—Efavirenz—acquired immunodeficiency syndrome	5.44e-05	0.000497	CcSEcCtD
Etoposide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.43e-05	0.000496	CcSEcCtD
Etoposide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.3e-05	0.000485	CcSEcCtD
Etoposide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.28e-05	0.000483	CcSEcCtD
Etoposide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	5.25e-05	0.00048	CcSEcCtD
Etoposide—ABCB1—brain—acquired immunodeficiency syndrome	5.25e-05	0.00141	CbGeAlD
Etoposide—Rash—Delavirdine—acquired immunodeficiency syndrome	5.23e-05	0.000478	CcSEcCtD
Etoposide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.23e-05	0.000478	CcSEcCtD
Etoposide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.23e-05	0.000478	CcSEcCtD
Etoposide—Headache—Delavirdine—acquired immunodeficiency syndrome	5.2e-05	0.000475	CcSEcCtD
Etoposide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	5.19e-05	0.000475	CcSEcCtD
Etoposide—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.15e-05	0.000471	CcSEcCtD
Etoposide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.08e-05	0.000464	CcSEcCtD
Etoposide—ABCB1—lymph node—acquired immunodeficiency syndrome	5.07e-05	0.00136	CbGeAlD
Etoposide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5.06e-05	0.000462	CcSEcCtD
Etoposide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	5.06e-05	0.000462	CcSEcCtD
Etoposide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.99e-05	0.000456	CcSEcCtD
Etoposide—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.93e-05	0.000451	CcSEcCtD
Etoposide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.89e-05	0.000447	CcSEcCtD
Etoposide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.88e-05	0.000446	CcSEcCtD
Etoposide—Rash—Ritonavir—acquired immunodeficiency syndrome	4.84e-05	0.000442	CcSEcCtD
Etoposide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.84e-05	0.000442	CcSEcCtD
Etoposide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.82e-05	0.000441	CcSEcCtD
Etoposide—Headache—Ritonavir—acquired immunodeficiency syndrome	4.81e-05	0.00044	CcSEcCtD
Etoposide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.7e-05	0.000429	CcSEcCtD
Etoposide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.66e-05	0.000426	CcSEcCtD
Etoposide—Rash—Saquinavir—acquired immunodeficiency syndrome	4.66e-05	0.000426	CcSEcCtD
Etoposide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.65e-05	0.000425	CcSEcCtD
Etoposide—Headache—Saquinavir—acquired immunodeficiency syndrome	4.63e-05	0.000423	CcSEcCtD
Etoposide—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.56e-05	0.000417	CcSEcCtD
Etoposide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.48e-05	0.00041	CcSEcCtD
Etoposide—Rash—Lamivudine—acquired immunodeficiency syndrome	4.44e-05	0.000406	CcSEcCtD
Etoposide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.44e-05	0.000406	CcSEcCtD
Etoposide—Headache—Lamivudine—acquired immunodeficiency syndrome	4.42e-05	0.000404	CcSEcCtD
Etoposide—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.39e-05	0.000401	CcSEcCtD
Etoposide—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.19e-05	0.000383	CcSEcCtD
